Features
Screener
Stocks Charts
Sign In Sign Up

Gujarat Alkalies & Chemicals Ltd. Fundamental Analysis Revenue, Profits & Valuation

NSE: GUJALKALI | BSE: 530001 | CHEMICALS - INORGANIC
Price ₹694.10 +₹19.30 (+2.86%)
P/E Ratio TTM
52-Week Range
Low ₹409 High ₹815
Market Cap ₹50.97B Billion
ROE -1.1% Annual

Market data as of Jul 27, 2026

This is a numbers-first look at Gujarat Alkalies & Chemicals Ltd. (GUJALKALI), covering income trends, margins, valuation, and shareholding.

Gujarat Alkalies Revenue Trend

At ₹4,165 Cr, Gujarat Alkalies & Chemicals Ltd.'s FY2025 revenue was 6.9% ahead of the ₹3,897 Cr posted in FY2024.

Stepping back, the 10-year revenue CAGR of 7.9% shows Gujarat Alkalies & Chemicals Ltd. has been growing at a moderate, sustainable pace.

In terms of scale, Gujarat Alkalies & Chemicals Ltd.'s ₹4,165 Cr in annual revenue positions it as a mid-sized chemicals - inorganic company.

Revenue Trend
YearRevenueYoY %
FY2025₹4,165 Cr+6.9%
FY2024₹3,897 Cr-14.5%
FY2023₹4,559 Cr+19.8%
FY2022₹3,805 Cr+56.6%
FY2021₹2,429 Cr

View Gujarat Alkalies & Chemicals Ltd.'s full 10-year revenue trend with CAGR analysis →

Gujarat Alkalies Profitability

On a per-share basis, diluted earnings were ₹-8.87 in FY2025 versus ₹-32.25 in FY2024.

Is Gujarat Alkalies Undervalued

Gujarat Alkalies & Chemicals Ltd. shares are currently trading at ₹694.10.

Craytheon calculates intrinsic value using the P/E Ratio, DCF, and EPS Growth models. All three appear in the Valuation Models cards below.

Share Price vs Book Value

10-year trend comparing market price with book value per share

FY 2016 - FY 2025

At the last close of ₹694.10, up 2.9% on the day, the stock's price history is charted above against its book value per share. It has traded between ₹409.15 and ₹815.00 over the past 52 weeks, and currently sits 14.8% below that high.

Valuation Models

P/E Ratio
Est. fair value

Fair value & verdict with a free account

Sign up free →
DCF
Est. fair value

Fair value & verdict for members

Upgrade →
EPS Growth
Est. fair value

Fair value & verdict for members

Upgrade →

Gujarat Alkalies Shareholding Pattern

An increase in promoter holding from 46.3% to 47.3% is a positive signal for the stock.

Foreign investors held 3.3% of the company as of June 2026, up year-over-year from 1.0%.

Domestic investors held 3.0% of the company as of June 2026, down year-over-year from 4.5%.

Shareholding Pattern (Last 4 Quarters)
QuarterPromoterFIIDIIPublic
Jun 202647.3%3.3%3.0%46.4%
Mar 202647.3%0.9%3.7%48.0%
Dec 202546.3%1.0%4.8%48.0%
Sep 202546.3%1.0%4.5%48.2%

Track quarterly shareholding changes for Gujarat Alkalies & Chemicals Ltd. →

Gujarat Alkalies Balance Sheet

Proportional view as of 27 Jul 2026. Hover blocks for details.

Assets

Liabilities & Equity

In FY2025, the total asset base came in at ₹79.87B, down 0.5% YoY from ₹80.23B.

Property, Plant & Equipment accounts for 58.4% of the total, ahead of Investments (24.5%) and Inventories (6.1%).

Capital structure: 71.0% equity, 6.9% debt, 22.1% operating liabilities. Over the year, debt is up 1.5% and equity is down 6.7%.

Balance sheet composition — FY 2025

Assets (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Cash & ST Investments 1.53B
Receivables 2.63B
Inventories 4.86B
Property, Plant & Equipment 46.62B
Investments 19.57B
Intangibles & Goodwill 13.30M
Other Assets 4.65B
Liabilities and equity (values in Indian Rupees, with M = millions, B = billions)
CategoryValue
Equity 56.70B
Short-term Debt 2.42B
Long-term Debt 3.09B
Trade Payables 5.89B
Other Liabilities 11.77B

View full balance sheet (multi-year) →

Gujarat Alkalies Investment Snapshot

To sum up Gujarat Alkalies & Chemicals Ltd.'s financial position: the data paints a clear picture for investors evaluating this chemicals - inorganic stock.

Revenue of ₹4,165 Cr in FY2025, up 6.9% year-over-year.

Long-term revenue has been compounding at 7.9% annually over 10 years.

The company reported a net loss of ₹65.1 Cr in FY2025.

Unlock Full Analysis

Get the complete view of Gujarat Alkalies & Chemicals Ltd. on Craytheon — 10 years of financials, three valuation models, and institutional holding trends.

Related Stocks